Increased levels of inflammatory biomarkers such as interleukin-6 (IL-6), 10 (IL-10), 1β (IL-1β), tumor necrosis factor-α (TNF-α) high-sensitivity C-reactive protein (hs-CRP) are associated with arterial stiffness in hypertension. Indeed, resistant hypertension (RHTN) leads to unfavorable prognosis attributed to poor blood pressure (BP) control and target organ damage. This study evaluated the potential impact of inflammatory biomarkers on arterial stiffness in RHTN.In this cross-sectional study, 32 RHTN, 20 mild hypertensive (HTN) and 20 normotensive (NT) patients were subjected to office BP and arterial stiffness measurements assessed by pulse wave velocity (PWV). Inflammatory biomarkers were measured in plasma samples.PWV was increased in RHTN compared with HTN and NT (p < 0.05). TNF-α levels were significantly higher in RHTN and HTN than NT patients. No differences in IL-6 levels were observed. RHTN patients had a higher frequency of subjects with increased levels of IL-10 and IL-1β compared with HTN and NT patients. Finally, IL-1β was independently associated with PWV (p < 0.001; R(2) = 0.5; β = 0.077).RHTN subjects have higher levels of inflammatory cytokines (TNF-α, IL-1β and IL-10) as well as increased arterial stiffness, and detectable IL-1β levels are associated arterial stiffness. These findings suggest that inflammation plays a possible role in the pathophysiology of RHTN.
Uma série de estudos mostra que a duração do período de amamentação tem uma relação inversa com o risco das mães desenvolverem Diabetes Mellitus tipo 2. O presente estudo dividiu fêmeas de camundongo em três grupos: Controle (Virgem), sem lactação após o parto (L0) e 21 dias de lactação após o parto (L21). Esses animais foram submetidos a dois ciclos de gestação e desmame. Dois meses depois do último desmame, as fêmeas foram submetidas ao teste de tolerância à glicose (GTT) e tolerância à insulina (ITT). Após o sacrifício dos animais, foram coletados fígado e pâncreas para rastreamento de lipídeos no tecido hepático, secreção de insulina e investigação de microRNAs (miRNAs) nas ilhotas pancreáticas. As fêmeas do grupo L21 apresentaram maior tolerância à glicose e não houve diferença na tolerância à insulina entre os grupos. No grupo L0, ocorreu maior acúmulo de gordura no fígado. As fêmeas do grupo L21 adquiriram maior capacidade de secretar insulina e o miRNA 7b-3p e 7a-3p estava menos expresso nesses mesmos animais.
Increased reactive oxygen species (ROS) production leads to tissue damage observed in sepsis and lipopolysaccharide (LPS)-exposed animals. LPS stimulates cytokines releasing, including tumor necrosis factor alpha (TNF-α), that is important to ROS production. Platelets, considered inflammatory cells, generate ROS when exposed to LPS in vivo, but not when they are incubated in vitro with this compound. Therefore, we investigated the role of TNF-α on the increased intraplatelet ROS levels after LPS treatment. Mice were injected with LPS (1 mg/kg) or TNF-α (10 ng/kg), and blood was collected to prepare the washed platelets. Animals were treated with infliximab (anti-TNF-α antibody), R-7050 (non-selective TNF-α receptor antagonist) or apocynin (NADPH oxidase inhibitor). At 48 h after LPS or TNF-α injection, the ROS levels in ADP (25 µM)-activated platelets were evaluated by flow cytometry. Our data showed that injection of mice with LPS increased by 4-fold the ROS production (p < 0.05), which was significantly reduced by the treatments with infliximab, R-7050 or apocynin. Injection of mice with TNF-α markedly elevated the ROS formation in platelets (p < 0.05) that was reduced by infliximab, R-7050 or apocynin treatments. In separate experiments, platelets from saline-injected mice were incubated with TNF-α (30 to 3000 pg/mL) in absence or presence of infliximab, R-7050, apocynin or GKT137831 (NOX1/NOX4 inhibitor) before ROS measurements. TNF-α in vitro markedly increased the ROS levels, an effect significantly reduced by all treatments. Therefore, platelets are involved in the oxidative stress induced by LPS through TNF-α action, and NADPH oxidase takes part in this effect.
Background: Obesity and type 2 diabetes (T2D) are global health challenges linked to the consumption of ultra processed foods high in sucrose. The latter sugar is one key source of excess dietary fructose. Although evidence indicates that excess fructose can negatively impact metabolic health and blood glucose regulation, the mechanisms are ill-defined. Excess dietary fructose overwhelms enterocyte absorption in the small intestine and spills over the distal gut. Interestingly, excess fructose has been linked to an expansion of the gut's absorptive surface and increased fat absorption. However, it remains uncertain whether excess dietary fructose impairs glucose tolerance by increasing gut absorptive surface and gut glucose absorption (GGA). Aims and Hypothesis: We hypothesized that dietary fructose impairs glucose tolerance by expanding gut surface and upregulating glucose transport machinery, which promotes increased GGA and glucose intolerance. We aim to (i) map the onset of altered glucose tolerance, plasma insulin, and altered GGA in mice fed a high-fructose diet, and (ii) investigate whether fructose driven increase in GGA correlates with an expansion of absorptive surface. Methodology: C57BL6J male mice were fed a high-sucrose (HS, with 8.5 %Kcal fructose) or a sucrose-free (CTL) diet. Oral glucose tolerance tests (OGTT) and 3-O-methyl-glucose (3-OMG) tests were conducted at weeks 1, 4, and 7 weeks after introduction of diets. Results: We found that 4 weeks, but not 1 week, on HS diet is suffcient to cause glucose intolerance, which persists, but is not aggravated, at week 7. Interestingly, HS-mice did not become insulin resistant, as revealed by plasma insulin levels, homa-ir, and insulin resistance index comparable to that of CTL-mice. HS-fed mice had longer small intestines than CTL-fed counterparts, which is indicative of increased absorptive surface. Furthermore, HS-fed mice presented higher plasma 3-OMG than CTL-mice at weeks 4 and 7, but not at week 1, indicating higher GGA that parallels the trajectory of deteriorated glucose tolerance. Conclusion: Changes in GGA and gut surface are early fructose-induced manifestations relevant to blood glucose control. We will next assess the expression of glucose transporters and perform morphometric analysis in the small intestine of these mice. We will also analyze how gut microbial populations correlate with fructose-induced changes to gut homeostasis. This study uncovers novel mechanisms by which dietary fructose contributes to impaired blood glucose control and elevates the risk of T2D. The findings from this work will lay the groundwork for novel approaches to address the growing burden of metabolic disorders worldwide. Laval university, CRIUCPQ, Fonds de recherche santé Québec. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
Swiss mice belong to an outbred strain of mice largely used as a model for experimental obesity induced by high fat diet (HFD). We have previously demonstrated that a given cohort of age-matched Swiss mice is hallmarked by heterogeneous changes in body weight when exposed to HFD. The reasons underlying such variability, however, are not completely understood. Therefore we aimed to clarify the mechanisms underlying the variability in spontaneous weight gain in age-matched male swiss mice. To achieve that, individuals in a cohort of age-matched male Swiss mice were categorized as prone to body mass gain (PBMG) and resistant to body mass gain (RBMG). PBMG animals had higher caloric intake and body mass gain. PBMG also showed increased midbrain levels of Tyrosine Hydroxilase (Th ) and ghrelin receptor ( Ghsr) mRNAs. The ratio of activated ghrelin normalized by total ghrelin exhibited a transitory increase 1h after refeeding exclusively in RBMG mice. Pharmacological blockade of Ghsr-1a failed to reduce food intake in PMBG mice. Accordingly, RBMG mice, but not PBMG mice, exhibited a reduction in the hypothalamic expression of the orexigenic gene AgRP when treated with the Ghsr-1a antagonist. Thus, the present data shows that RBMG mice have a hypothalamic homeostatic control of food intake that is sensitive to GHS-R1a/ghrelin signaling and controls AgRP1. Individuals classified as PBMG display increased midbrain expression of Th , Drd1 and Drd2 and increased food intake that is not sensitive to GHS-R1a inhibition.
Agomelatine (AGO) is an antidepressant drug with agonistic activity at melatonin receptor 1 (MT1) and MT2 and with neutral antagonistic activity at serotonin receptor 5-HT2C. Although experimental studies show that melatonin reduces hypertriglyceridemia and hepatic steatosis induced by excessive fructose intake, no studies have tested if AGO exerts similar actions. To address this issue we have treated male Wistar rats with fructose (15% in the drinking water) and/or AGO (40 mg/kg/day) for two weeks. AGO reduced body weight gain, feeding efficiency and hepatic lipid levels without affecting caloric intake in fructose-treated rats. AGO has also decreased very low-density lipoprotein (VLDL) production and circulating TAG levels after an oral load with olive oil. Accordingly, treatment with AGO reduced the hepatic expression of fatty acid synthase (Fasn), a limiting step for hepatic de novo lipogenesis (DNLG). The expression of apolipoprotein B (Apob) and microsomal triglyceride transfer protein (Mttp) in the ileum, two crucial proteins for intestinal lipoprotein production, were also downregulated by treatment with AGO. Altogether, the present data show that AGO mimics the metabolic benefits of melatonin when used in fructose-treated rats. This study also suggests that it is relevant to evaluate the potential of AGO to treat metabolic disorders in future clinical trials.
ABSTRACT Air pollution is comprised of several substances, including particulate matter (PM). Exposure to air pollution may trigger alterations in DNA methylation thus modifying gene expression patterns. This phenomenon is likely to mediate the relationship between exposure to air pollution and adverse health effects. The purpose of this study was analyzing the effects of exposure to PM 2.5 during pregnancy or lactation and whether it would cause multigenerational epigenetic alterations in the promoter region of the genes Pdx1 and NEUROG3 within mouse pancreatic islets. Our results show that maternal exposure to PM 2.5 led to an elevation in blood glucose levels within the two following generations (F1 and F2). There was also an increase in DNA methylation in the aforementioned promoter regions accompanied by reduced gene expression in generations F1 and F2 upon F0 exposure to PM 2.5 during pregnancy. These data suggest that maternal exposure to PM 2.5 from air pollution, particularly during pregnancy, may lead to a multigenerational and lifelong negative impact on glucose homeostasis mediated by an increase in DNA methylation within the promoter region of the genes Pdx1 and NEUROG3 in pancreatic islets.